ITMCTR2100004926尚未招募1 期
Efficacy and safety of Yifei Sanjie Recipe combined with anlotinib in the treatment of the second line or above IIIB-IVB non-small cell lung cancer patients: a pilot study
The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 年龄范围
- 18 至 80(—)
- 性别
- All
入选标准
- •1. Pathologically and/or cytologically diagnose with IIIB-IVB non-small cell lung cancer;
- •2. Patients with negative driver genes who have received at least one type of systemic chemotherapy (including combined immune checkpoint inhibitors or anti-vascular drug therapy) have progressed, relapsed, or become intolerable; Patients with positive driver gene (EGFR mutation or ALK fusion positive) who have progressed, relapsed, or become intolerable after receiving corresponding standard targeted drug therapy;
- •3. Aged from 18 to 75 years, male or female;
- •4. Eastern Cooperative Oncology Group (ECOG) performance scale (PS) score of 0-2;
- •5. The expected survival time>=24 weeks;
- •6. A measurable lesion based on the RECIST criteria;
- •7. Adequate liver and kidney function (creatinine clearance rate>=60ml/min; total bilirubin<=1.5xULN; alanine aminotransferase, aspartate aminotransferase<=2.5xULN));
- •8. Hemoglobin>100g/L, platelet count>100x10^9/L, neutrophils>1.5x10^9/L;
- •9. Agree to contraception during the trial and within six months after the trial ends;
- •10. Patients or their family members signed the informed consent.
排除标准
- •1. With unstable brain metastases or at risk of bleeding after being evaluated by researchers;
- •2. Previously used anlotinib or apatinib;
- •3. Concomitant with other types of malignant tumors;
- •4. Difficulties with oral medications (such as dysphagia, chronic diarrhea, and intestinal obstruction);
- •5. Female patients with positive pregnancy test results 7 days before enrollment;
- •6. Women who are pregnant or breastfeeding;
- •7. Patients with mental illness or mental retardation;
- •8. Allergy or intolerance to the study drug.
研究者
相似试验
招募中
1 期
Efficacy and safety of Yifei Sanjie Recipe in the treatment of chemotherapy-related cancer-related fatigue in patients with non-small cell lung cancer: a N-of -1 multicenter randomized controlled trialITMCTR2100004951The First Affiliated Hospital of Guangzhou University of Chinese Medicine
尚未招募
不适用
Effectiveness and safety of Yifei Sanjie Granule in people with Pulmonary Mixed Nodules: A prospective controlled studyPulmonary Mixed NodulesITMCTR2200006146The Third Affiliated Hospital of Henan University of Chinese Medicine
已完成
不适用
Treatment of Jianpi Shugan recipe in the treatment of diarrhoea-predominant irritable bowel syndrome (IBS-D)Diarrhoea-predominant irritable bowel syndrome (IBS-D)Digestive SystemIrritable bowel syndrome with diarrhoeaISRCTN66631530Beijing Hospital of Traditional Chinese Medicine Affiliated to Capital Medical University260
招募中
1 期
Clinical study of Jianpi Sanjie Recipe in prevention and treatment of drug resistance of colorectal cancercolorectal cancerITMCTR2000003793Shanghai Hospital of traditional Chinese Medicine
尚未招募
1 期
Clinical study of Jianpi Jiedu recipe combined with SOX chemotherapy in the first-line treatment of advanced gastric cancerGastric cancerITMCTR2000003833Shuguang hospital affiliated to Shanghai university of traditional Chinese medicine
